Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,867 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00904410 | Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET(CHIMTEP) | completed | Phase 4 | 63 | Centre Oscar LambretOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT05206331 | CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study | completed | Phase 4 | 2,089 | Margarita Louise ZuleyOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT04016376 | Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction | completed | Phase 4 | 1,507 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 4, 2026 | clinicaltrials |
| NCT05562518 | GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.(GRACE) | completed | Phase 4 | 31 | University Hospital, GhentOTHER | 1 | Aug 13, 2026 | clinicaltrials |
| NCT05631795 | Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment(ALPINIST) | completed | Phase 4 | 40 | Novartis PharmaceuticalsINDUSTRY | 1 | Jul 9, 2026 | clinicaltrials |
| NCT05365230 | A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer | completed | Phase 4 | 261 | Ottawa Hospital Research InstituteOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT03664687 | Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL)(REaCT-ZOL) | completed | Phase 4 | 211 | Ottawa Hospital Research InstituteOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT04764292 | Screening Contrast-Enhanced Mammography as an Alternative to MRI(SCEMAM) | completed | Phase 4 | 615 | Wendie BergOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT01574170 | Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival(METAL3) | completed | Phase 4 | 267 | Institut Claudius RegaudOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT01127295 | Pharmacology of Adjuvant Hormonotherapy in Breast Cancer(PHACS) | completed | Phase 4 | 2,000 | Institut Claudius RegaudOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT01553903 | Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not(OXYTAM) | completed | Phase 4 | 29 | Institut Claudius RegaudOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT01612871 | Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer(MIRHO) | completed | Phase 4 | 39 | Institut Claudius RegaudOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT07487129 | Clinical and Pharmacoeconomic Assessment of CDK4/6 Inhibitors for Treatment of Breast Cancer in Egypt(Clinical and P) | completed | Phase 4 | 206 | Beni-Suef UniversityOTHER | 1 | Mar 23, 2026 | clinicaltrials |
| NCT04024254 | A Study of Serum Folate Levels in Patients Treated With Olaparib | completed | Phase 4 | 10 | Rush University Medical CenterOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT04864405 | Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and Compliance | completed | Phase 4 | 245 | Ottawa Hospital Research InstituteOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT02696707 | An Integrated Consent Model Study to Compare Two Standard of Care Schedules for Monitoring Cardiac Function in Patients Receiving Trastuzumab for Early Stage Breast Cancer(OTT 15-05) | completed | Phase 4 | 200 | Ottawa Hospital Research InstituteOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT05222464 | Utilizing MyChart to Assess the Effectiveness of Interventions for Vasomotor Symptoms: A Feasibility Study | completed | Phase 4 | 56 | Ottawa Hospital Research InstituteOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT00370240 | Chlorhydrate of Ropivacaine and Breast Cancer Surgery | completed | Phase 4 | 260 | Institut CurieOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT05732064 | Dexmedetomidine-esketamine Combined Nasal Administration and Perioperative Sleep Quality | completed | Phase 4 | 180 | Peking University First HospitalOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT01490892 | Quantitative Subharmonic Breast Imaging | completed | Phase 4 | 219 | Thomas Jefferson UniversityOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT04781959 | A Randomized, Multicenter Pragmatic Trial Comparing Bone Pain From a Single Dose of Pegfilgrastim to 5 Doses of Daily Filgrastim in Breast Cancer Patients Receiving Neoadjuvant/Adjuvant Chemotherapy | completed | Phase 4 | 233 | Ottawa Hospital Research InstituteOTHER | 1 | Mar 21, 2025 | clinicaltrials |
| NCT04330040 | Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast Cancer(SOLI) | completed | Phase 4 | 202 | AstraZenecaINDUSTRY | 1 | Mar 10, 2025 | clinicaltrials |
| NCT02661932 | Fertility Preservation in Breast Cancer Patients(Brovale) | completed | Phase 4 | 65 | Erasme University HospitalOTHER | 1 | Jan 31, 2025 | clinicaltrials |
| NCT04931615 | ARTISS a Single-centre Randomised Control Study(ARTISS) | completed | Phase 4 | 135 | Mid and South Essex NHS Foundation TrustOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT04707196 | A Study of Abemaciclib in Indian Women With Advanced Breast Cancer | completed | Phase 4 | 200 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 24, 2023 | clinicaltrials |
| NCT00172029 | Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid | completed | Phase 4 | 116 | NovartisINDUSTRY | 1 | Aug 18, 2023 | clinicaltrials |
| NCT05840068 | IGF Level in Breast Cancer Patients Treated With Metformin | completed | Phase 4 | 107 | Beni-Suef UniversityOTHER | 1 | May 3, 2023 | clinicaltrials |
| NCT00128297 | Pamidronate Administration in Breast Cancer Patients With Bone Metastases | completed | Phase 4 | 152 | Spanish Breast Cancer Research GroupOTHER | 1 | Mar 28, 2023 | clinicaltrials |
| NCT01298193 | Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer. | completed | Phase 4 | 212 | Spanish Breast Cancer Research GroupOTHER | 1 | Mar 7, 2023 | clinicaltrials |
| NCT00128778 | Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients | completed | Phase 4 | 288 | Spanish Breast Cancer Research GroupOTHER | 1 | Mar 6, 2023 | clinicaltrials |
| NCT04248179 | The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery. | completed | Phase 4 | 36 | Zealand University HospitalOTHER | 1 | Feb 9, 2023 | clinicaltrials |
| NCT01975064 | Cancer and Anesthesia: Survival After Radical Surgery - a Comparison Between Propofol or Sevoflurane Anesthesia(CAN) | completed | Phase 4 | 5,774 | Uppsala UniversityOTHER | 3 | Dec 14, 2022 | clinicaltrials |
| NCT01035099 | RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVF | completed | Phase 4 | 41 | Weill Medical College of Cornell UniversityOTHER | 1 | Dec 13, 2022 | clinicaltrials |
| NCT02549677 | Epirubicin Versus Docetaxel Plus Cyclophosphamide in Lymph Node Negative, ER-positive, Her2-negative Breast Cancer(ELEGANT) | completed | Phase 4 | 294 | Ruijin HospitalOTHER | 1 | Oct 27, 2022 | clinicaltrials |
| NCT02419742 | Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen | completed | Phase 4 | 110 | Hoffmann-La RocheINDUSTRY | 1 | Oct 12, 2022 | clinicaltrials |
| NCT03948568 | Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)(REaCT-RETT) | completed | Phase 4 | 262 | Ottawa Hospital Research InstituteOTHER | 1 | Sep 30, 2022 | clinicaltrials |
| NCT02679755 | Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer | completed | Phase 4 | 252 | PfizerINDUSTRY | 2 | Jul 27, 2022 | clinicaltrials |
| NCT04074460 | Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study(VAPOR-C) | completed | Phase 4 | 169 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Jun 9, 2022 | clinicaltrials |
| NCT04705883 | Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors(VIBRA) | completed | Phase 4 | 10 | Hospital Clinic of BarcelonaOTHER | 1 | Feb 22, 2022 | clinicaltrials |
| NCT04726878 | ESP in Breast Surgery Due to Cancer | completed | Phase 4 | 75 | Medical University of LublinOTHER | 1 | Nov 9, 2021 | clinicaltrials |
| NCT01176916 | Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China | completed | Phase 4 | 564 | PfizerINDUSTRY | 1 | Oct 27, 2021 | clinicaltrials |
| NCT02479347 | Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodine | completed | Phase 4 | 2,158 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Sep 9, 2021 | clinicaltrials |
| NCT03511378 | Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast Cancer | completed | Phase 4 | 138 | Lupin Ltd.INDUSTRY | 1 | Jun 15, 2021 | clinicaltrials |
| NCT00688909 | Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer(REAL) | completed | Phase 4 | 261 | Novartis PharmaceuticalsINDUSTRY | 1 | Jun 9, 2021 | clinicaltrials |
| NCT03038152 | Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing Surgery | completed | Phase 4 | 54 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 5, 2021 | clinicaltrials |
| NCT02864030 | PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment | completed | Phase 4 | 200 | Oncologia Medica dell'Ospedale FatebenefratelliOTHER_GOV | 1 | Mar 4, 2021 | clinicaltrials |
| NCT02721433 | 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases(REaCT-BTA) | completed | Phase 4 | 263 | Ottawa Hospital Research InstituteOTHER | 1 | Dec 2, 2020 | clinicaltrials |
Data updated 13 days agoSource updated Sep 17, 2026source: clinicaltrials